Involvement of oxidative stress in the pathogenesis of diabetes

Antioxidants and Redox Signaling

Volumn 9, Issue 3, 2007, Pages 355-366

  Kaneto, Hideaki ^a   Katakami, Naoto ^a   Kawamori, Dan ^a   Miyatsuka, Takeshi ^a   Sakamoto, Ken'ya ^a   Matsuoka, Taka Aki ^a   Matsuhisa, Munehide ^a   Yamasaki, Yoshimitsu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; STRESS ACTIVATED PROTEIN KINASE;

ATHEROSCLEROSIS; AUTOIMMUNITY; CELL DESTRUCTION; CELL INFILTRATION; DETERIORATION; DISEASE COURSE; DISEASE EXACERBATION; ENZYME ACTIVATION; HUMAN; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MAP KINASE KINASE 4; OXIDATIVE STRESS;

EID: 33846434443     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.1465     Document Type: Review

References (139)

1. 307. J Biol Chem 275: 9047-9054, 2000.
2. Ahlgren U, Jonsson J, Jonsson L, Simu K, and Edlund H. β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes Dev 12: 1763-1768, 1998.
3. Ammendrup A, Maillard A, Nielsen K, Aabenhus AN, Serup P, Dragsbaek MO, Mandrup-Poulsen T, and Bonny C. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 49: 1468-1476, 2000
4. Andersen HU, Jorgensen KH, Egeberg J, Mandrup-Poulsen T, and Nerup J. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43: 770-777, 1994.
5. Andersen NA, Larsen CM, and Mandrup-Poulsen T. TNFalpha and IFNgamma potentiate IL-1beta induced mitogen activated protein kinase activity in rat pancreatic islets of Langerhans. Diabetologia 43: 1389-1396, 2000.
6. Ankarcrona M, Dypbukt JM, Brune B, and Nicotera P. Interleukin-1 β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213: 172-177, 1994.
7. Azumi H. Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, and Yokoyama M. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 22: 1838-1844, 2002.
8. Barry-Lane P, Patterson C, van der Merwe M, Hu Z, Holland S, Yeh E, and Runge M. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108: 1513-1522, 2001.
9. Baynes JW and Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
10. Bertera S, Crawford ML, Alexander AM, Papworth GD, Watkins SC, Robbins PD, and Trucco M. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 52: 387-393, 2003.
11. Bonny C, Nicod P, and Waeber G. IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J Biol Chem 273: 1843-1846, 1998.
12. Bonny C, Oberson A, Steinmann M, Schorderet DF, Nicod P, and Waeber G. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J Biol Chem 275: 16466-16472, 2000.
13. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50: 77-82, 2001
14. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
15. Calver A, Collier J, and Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90: 2548-2554, 1992.
16. Chakravarthy U, Hayes RG, Stitt AW, McAuley E, and Archer DB. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 47: 945-952, 1998.
17. Chen H, Li X, and Epstein PN. MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity. Diabetes 54: 1437-1446, 2005.
18. Corbett JA, Lancaster JR Jr, Sweetland MA, and McDaniel ML. Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. J Biol Chem 266: 21351-21354, 1991.
19. Corbett JA, Wang JL, Sweetland MA, Jack R, Lancaster JR Jr, and McDaniel ML. Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. J Clin Invest 90: 2384-2391, 1992.
20. Corbett JA, and McDaniel ML. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 181: 559-568, 1995.
21. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, and Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 347: 444-445, 1996.
22. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, and Griendling KK. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329: 653-657, 1998.
23. Delafontaine P and Ku L. Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells. Cardiovasc Res 33: 216-222, 1997.
24. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, and Davis RJ. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277: 696-696, 1997.
25. Dilts SM, Solvason N, and Lafferty KJ. The role of CD4 and CD8 T cells in the development of autoimmune diabetes. J Autoimmun 13: 285-290, 1999.
26. Donath MY, Storing J, Maedler K, and Mandrup-Poulsen T. Inflammatory mediators and islet β-cell failure; a link between type 1 and type 2 diabetes. J Mol Med 81: 455-470, 2003.
27. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, and Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci U S A 91: 9253-9256, 1994.
28. Eizirik DL and Mandrup-Poulsen T. A choice of death: the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44: 2115-2133, 2001.
29. Elliott G and O'Hare P. Intracellular trafficking and protein delivery by a herpesvirus structure protein. Cell 88: 223-233, 1997.
30. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Rev 23: 599-622, 2002.
31. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52: 1-8, 2003.
32. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, and Karasik A. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 6: 568-572, 2000.
33. Fortuno A, San Jose G, Moreno MU, Beloqui O, Diez J, and Zalba G. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 55: 209-215, 2006.
34. Frankel AD and Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55: 1189-1193, 1988.
35. Gorogawa S, Kajimoto Y, Umayahara U, Kaneto H, Watada H, Kuroda A, Kawamori D, Yasuda T, Matsuhisa M, Yamasaki Y, and Hori M. Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 57: 1-10, 2002.
36. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, and Channon KM. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102: 1744-1777, 2000.
37. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
38. Haber CA, Lam TK, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, and Fantus IG. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 285: E744-E753, 2003.
39. Harmon JS, Stein R, and Robertson RP. Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem 280: 11107-11113, 2005.
40. Harrison D, Griendling KK, Landmesser U, Hornig B, and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91: 7A-11A, 2003.
41. Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka K, Hatazaki M, Hazama Y, and Hori M. Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 262: 458-463, 2003.
42. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14-E22, 2001.
43. Hirosumi J, Tuncman G, Chang L, Karin M, and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
44. Hohmeier HE, Thigpen A, Tran VV, Davis R, and Newgard CB. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101: 1811-1820, 1998.
45. Holland AM, Hale MA, Kagami H, Hammer RE, and MacDonald RJ. Experimental control of pancreatic development and maintenance. Proc Natl Acad Sci U S A 99: 12236-12241, 2002.
46. Hotamisligil G. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. Diabetes 54: S73-S78, 2005.
47. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J, and Miyazaki J: Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med 188: 1445-1451, 1998.
48. Hu Y, Cheng L, Hochleitner BW, and Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol 17: 2808-2816, 1997.
49. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, and Yamada Y. Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932, 1999.
50. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
51. 2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res 88: 1120-1126, 2001.
52. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, and Rett K. Oral administration of RACalpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 27: 309-314, 1999.
53. Jaeschke A, Rincon M, Doran B, Reilly J, Neuberg D, Greiner DL, Shultz LD, Rossini AA, Flavell RA, and Davis RJ. Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes. Proc Natl Acad Sci U S A 102: 6931-6935, 2005.
54. Jonas JC, Sharma A, Hasenkamp W, Iikova H, Patane G, Laybutt R, Bonner-Weir S, and Weir GC. Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes. J Biol Chem 274: 14112-14121, 1999.
55. Jonsson J, Carlsson L, Edlund T, and Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 37: 606-609, 1994.
56. Kajimoto Y, Matsuoka T, Kaneto H, Watada H, Fujitani Y, Kishimoto M, Sakamoto K, Matsuhisa M, Kawamori R, Yamasaki Y, and Hori M. Induction of glycation suppresses glucokinase gene expression in HIT-T15 cells. Diabetologia 42: 1417-1424, 1999.
57. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura N, Tatsumi H, Yamasaki Y, Kamada T, and Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44: 733-738, 1995.
58. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, and Hori M. Beneficial effects of antioxidants for diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48: 2398-2406, 1999.
59. Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, and Weir GC. Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function by provoking oxidative stress. J Biol Chem 276: 31099-31104, 2001.
60. Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, and Weir GC. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277: 30010-30018, 2002.
61. Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka T, Matsuhisa M, Kajimoto Y, Ichijo H, Yamasaki Y, and Hori M. Possible novel therapy for diabetes with cell-permeable JNK inhibitory peptide. Nat Med 10: 1128-1132, 2004.
62. Kaneto H, Matsuoka T, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, and Yamasaki Y. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes. J Mol Med 83: 429-439, 2005.
63. Kaneto H, Matsuoka T, Nakatani Y, Miyatsuka T, Matsuhisa M, Hori M, and Yamasaki Y. A crucial role of MafA as a novel therapeutic target for diabetes. J Biol Chem 280: 15047-15052, 2005.
64. Katakami N, Kaneto H, Hao H, Umayahara Y, Fujitani Y, Sakamoto K, Gorogawa S, Yasuda T, Kawamori D, Kajimoto Y, Matsuhisa M, Yutani C, Hori M, and Yamasaki Y. Role of pim-1 in smooth muscle cell proliferation. J Biol Chem 279: 54742-54749, 2004.
65. Katakami N, Yamasaki Y, Hayaishi R, Ohtoshi K, Kaneto H, Matsuhisa M, Kosugi K, and Hori M. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Diabetologia 47: 1906-1923, 2004.
66. Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M, Handa H. MafA is a glucose-regulated and pancreatic β-cell-specific transcriptional activator for the insulin gene. J Biol Chem 277: 49903-49910, 2002.
67. Kawamori D, Kajimoto Y, Kaneto H, Umayahara Y, Fujitani Y, Miyatsuka T, Watada H, Leibiger IB, Yamasaki Y, and Hori M. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun N-terminal kinase. Diabetes 52: 2896-2904, 2003.
68. Kawamori D, Kaneto H, Nakatani Y, Matsuoka T, Matsuhisa M, Hori M, and Yamasaki Y. The forkhead transcription factor Foxol bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281: 1091-1098, 2006.
69. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, and Kadada T. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 15: 1290-1294, 1992.
70. Kim S, Izumi Y, Yano M, Hamaguchi A, Miura K, Yamanaka S, Miyazaki H, and Iwao H. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 97: 1731-1737, 1998.
71. Kim YK, Lee MS, Son SM, Kim IJ, Lee WS, Rhim BY, Hong KW, and Kim CD. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51: 522-527, 2002.
72. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, and Usadel KH. a-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22: 280-287, 1999.
73. Koyama H, Olson NE, Dastvan FF, and Reidy MA. Cell replication in the arterial wall: activation of signaling pathway following in vivo injury. Circ Res 82: 713-721, 1998.
74. Kubisch HM, Wang J, Luche R, Carlson E, Bray TM, Epstein CJ, and Phillips JP. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci U S A 91: 9956-9959, 1994.
75. Kubisch HM, Wang JQ, Bray TM, and Phillips JP. Targeted overexpression of Cu/Zu superoxide-dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 46: 1563-1566, 1997.
76. Larsen CM, Wadt KA, Juhl LF, Andersen HU, Karlsen AE, Su MS, Seedorf K, Shapiro L, Dinarello CA, and Mandrup-Poulsen T. Interleukin-1 beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem 273: 152940-153001, 1998.
77. Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villen J, Becker EBE, DiBacco S, de la Iglesia N, Gygi S, Blackwell TK, and Bonni A. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001, 2006.
78. Lenzen S, Drinkgern J, and Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20: 463-466, 1996.
79. Leonard J, Peers B, Johnson T, Ferreri K, Lee S, and Montminy MR. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol 7: 1275-1283, 1993.
80. Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, and Lenzen S. Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes 49: 1123-1130, 2000.
81. Madamanchi NR, Vendrov A, and Runge MS. Oxidative stress and vascular disease. Artheroscler Thromb Vasc Biol 25: 29-35, 2005.
82. Maechler P, Jornot L, and Wollheim CB. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem 274: 27905-27913, 1999
83. Major CD and Wolf BA. Interleukin-lbeta stimulation of c-Jun NH (2)-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction. Diabetes 50: 2721-2728, 2001.
84. Mandrup-Poulsen T. Beta cell death and protection. Ann N Y Acad Sci 1005: 32-42, 2003.
85. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, and Yamasaki Y. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99: 144-150, 1997
86. Matsuoka T, Zhao L, Artner I, Jarrett HW, Friedman D, Means A, and Stein R. Members of the large Maf transcription family regulate insulin gene transcription in islet β cells. Mol Cell Biol 23: 6049-6062, 2003.
87. Matsuoka T, Artner I, Henderson E, Means A, Sander M, and Stein R. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci U S A 101: 2930-2933, 2004.
88. Mehta JL, Rasouli N, Sinha AK, and Molavi B. Mehta JL, Rasouli N, Sinha AK Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol 38: 794-803, 2006.
89. Miller CP, McGehee RE, and Habener JF. IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J 13: 1145-1156, 1994.
90. Miyazaki S, Yamato E, and Miyazaki J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 53: 1030-1037, 2004.
91. Miyazaki S, Miyazaki T, Tashiro F, Yamato E, and Miyazaki, J. Development of a single-cassette system for spatiotemporal gene regulation in mice. Biochem Biophys Res Commun 338, 1083-1088, 2005
92. Mohazzab KM, Kaminski PM, and Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Phyiol 266: H2568-H2572, 1994.
93. Moran A, Zhang H-J, Olson LK, Harmon JS, Poitout V, and Robertson RP. Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15. J Clin Invest 99: 534-539, 1997.
94. Moritoh Y, Yamato E, Yasui Y, Miyazaki S, and Miyazaki J. Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 52: 1163-1168, 2003.
95. Kip1 induces cell migration. Nat Med 4: 1449-1452, 1998.
96. Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka T, Kajimoto Y, Matsuhisa M, Yamasaki Y, and Hori M. Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 279: 45803-45809, 2004.
97. Noguchi H, Kaneto H, Weir GC, Bonner-Weir S. PDX-1 protein containing its own Antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 52: 1732-1737, 2003.
98. Noguchi H, Matsushita M, Okitsu T, Moriwaki A, Tomizawa K, Kang S, Li ST, Kobayashi N, Matsumoto S, Tanaka K, Tanaka N, and Matsui H. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 10: 305-309, 2004.
99. Ohlsson H, Karlsson K, and Edlund T. 1PF1, a homeodomain-containing- transactivator of the insulin gene. EMBO J 12: 4251-4259, 1993.
100. Olbrot M, Rud J, Moss LG, and Sharma A. Identification of β-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci U S A 99: 6737-6742, 2002.
101. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, and Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274: 19814-19822, 1999.
102. Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, and Haskins K. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 51: 347-355, 2002.
103. Poitout V, Olson LK, and Robertson RP. Chronic exposure of bTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest 97: 1041-1046, 1996.
104. Poitout V and Robertson RP. Minireview: secondary beta-cell failure in type 2 diabetes: a convergence of glucotoxicity and lipotoxicity. Endocrinology 143: 339-342, 2002.
105. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43: 613-621, 1994.
106. Rao GN and Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70: 593-599, 1992.
107. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, Hersberger M, Eriksson U, Eberli FR, Becher B, Boren J, Chen M, Cybulsky MI, Moore KJ, Freeman MW, Wagner EF, Matter CM, and Luscher TF. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 306: 1558-1561, 2004.
108. Robertson RP, Harmon J, Tran PO, Tanaka Y, and Takahashi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52: 581-587, 2003
109. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 271: 42351-42354, 2004
110. Rothbard JB, Garlington S, Lin Q, Kirschberg T, Kreider E, McGrane PL, Wender PA, and Khavari PA. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 6: 1253-1257, 2000.
111. Rudich A, Tirosh A., Potashnik R, Hemi R, Kanety H, and Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47: 1562-1569, 1998.
112. Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, and Araki E. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells. Biochem Biophys Res Commun 300: 216-222, 2003.
113. Sakamoto K, Yamasaki Y, Kaneto H, Fujitani Y, Matsuoka T, Yoshioka R, Tagawa T, Kajimoto Y, and Hori M. Identification of oxidative stress-regulated genes in rat aortic smooth muscle cells by suppression subtractive hybridization. FEBS Lett 12: 47-51, 1999.
114. Schwarze SR, Ho A, Vocero-Akbani AM, and Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572, 1999.
115. Sharma A, Fusco-DeMane D, Henderson E, Efrat S, and Stein R. The role of the insulin control element and RIPE3b1 activators in glucose-stimulated transcription of the insulin gene. Mol Endocrinol 9: 1468-1488, 1995.
116. Shimabukuro M, Ohneda M, Lee Y, and Unger RH. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 46: 1276-1280, 1997.
117. Shimabukuro M, Zhou YT, Levi M, and Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95: 2498-2502, 1998.
118. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, and Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-786, 1996.
119. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, and Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15: 106-110, 1997.
120. Suarez-Pinzon WL, Szabo C, and Rabinovitch A. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes 46: 907-911, 1997.
121. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
122. Tabatabaie T, Vasquez-Weldon A, Moore DR, and Kotake Y. Free radicals and the pathogenesis of type 1 diabetes: β-cell cytokine-mediated free radical generation via cyclooxygenase-2. Diabetes 52: 1994-1999, 2003.
123. Tanaka Y, Gleason CE, Tran POT, Harmon JS, and Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96: 10857-10862, 1999.
124. Tanaka Y, Tran POT, Harmon J, and Robertson RP. A role of glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A 99: 12363-12368, 2002.
125. Taniguchi H, Yamato E, Tashiro F, Ikegami H, Ogihara T, and Miyazaki J. β-Cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas. Gene Ther 10: 15-23, 2003.
126. Tardif JC, Cote G, Lesperance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, and de Guise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group. N Engl J Med 337: 365-372, 1997.
127. Tiedge M, Lortz S, Munday R, and Lenzen S. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47: 1578-1585, 1998.
128. Tirosh A, Potashnik R, Bashan N, and Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes: a putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274: 10595-10602, 1999.
129. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, and Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321, 1996.
130. Waeber G, Delplanque J, Bonny C, Mooser V, Steinmann M, Widmann C, Maillard A, Miklossy J, Dina C, Hani EH, Vionnet N, Nicod P, Boutin P, and Froguel P. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 24: 291-295, 2000.
131. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, and Sharma A. β-Cell adaptation and decompensation during the progression of diabetes. Diabetes 50: S154-S159, 2001.
132. Wellen KE and Hotamisligil G. Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119, 2005.
133. Welsh N. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 271: 8307-8312, 1996.
134. Wong FS and Janeway CA Jr. The role of CD4 vs. CD8 T cells in IDDM. J Autoimmun 13: 290-295, 1999.
135. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y, Morishima T, and Kadada T. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43: 634-639, 1994.
136. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M, Kajimoto Y, and Kadada T. Asymptomatic hyperglycaemia is associated with increased intimai plus medial thickness of the carotid artery. Diabetologia 38: 585-591, 1995.
137. Yamasaki Y, Katakami N, Hayaishi-Okano R, Matsuhisa M, Kajimoto Y, Kosugi K, Hatano M, and Hori M. a-Glucosidase inhibitor reduces the progression of carotid intima-media thickness. Diabetes Res Clin Pract 67: 204-210, 2005.
138. Yoshizumi M, Abe J, Haendeler J, Huang Q, and Berk BC. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 275: 11706-11712, 2000.
139. Zhang C, Moriguchi T, Kajihara M, Esaki R, Harada A, Shimohata H, Oishi H, Hamada M, Morito N, Hasegawa K, Kudo T, Engel JD, Yamamoto M, and Takahashi S. MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell Biol 25: 4969-4976, 2005.